The serum CK 19 fragment (CYFRA 21-1) stands out as a circulating marker in dedifferentiated thyroid cancers such as anaplastic thyroid carcinoma and poorly differentiated carcinoma [36,37]. The gene discussed is KRT19; the disease is thyroid gland carcinoma.